Meeder Asset Management Inc Athersys, Inc Transaction History

Meeder Asset Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$1.41 - $1.94 $1 - $1	-1 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$1.61 - $2.77 $1 - $2	1 New	1 $0
Q3 2020 Nov 02, 2020	SELL	$1.91 - $3.08 $4,608 - $7,432	-2,413 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$1.97 - $3.98 $158,118 - $319,446	-80,263 Reduced 97.08%	2,413 $7,000
Q1 2020 May 15, 2020	BUY	$1.17 - $3.0 $96,730 - $248,028	82,676 New	82,676 $248,000
Q4 2019 Feb 13, 2020	SELL	$1.16 - $1.42 $1,508 - $1,846	-1,300 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$1.39 - $2.03 $1,806 - $2,638	1,300 New	1,300 $2,000
Q1 2019 Apr 16, 2019	SELL	$1.39 - $1.71 $2,809 - $3,455	-2,021 Closed	0 $0
Q4 2018 Jan 17, 2019	BUY	$1.41 - $2.16 $2,849 - $4,365	2,021 New	2,021 $3,000
Q1 2018 May 03, 2018	SELL	$1.34 - $2.03 $1,285 - $1,946	-959 Closed	0 $0
Q4 2017 Feb 02, 2018	SELL	$1.65 - $2.45 $669 - $994	-406 Reduced 29.74%	959 $2,000
Q3 2017 Oct 20, 2017	BUY	$1.5 - $2.55 $2,047 - $3,480	1,365	1,365 $3,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.